ABILIFY MAINTENA 400mg PFS (Aripiprazole PFS) 400mg x 2ml

ABILIFY MAINTENA 400mg PFS (Aripiprazole) is a long-acting injectable antipsychotic used for schizophrenia and bipolar disorder maintenance. This 400mg strength prefilled syringe offers convenient once-monthly dosing. Ideal for stable patients seeking consistent symptom control.

Strength

400mg x 2ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Otsuka America Pharmaceutical, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ABILIFY MAINTENA 400mg PFS is used to treat schizophrenia and maintain stability in bipolar I disorder. It helps reduce symptoms like hallucinations, delusions, and mood swings. This long-acting injection supports consistent medication adherence for ongoing symptom management. Patients may ask what is aripiprazole injection used for to understand its role in mental health treatment.

Side Effects

This injection may help stabilize mood and reduce psychotic symptoms over time. Patients often report improved daily functioning and fewer acute episodes. The effects develop gradually as the medication reaches steady levels in the body. Individual responses vary based on treatment history and diagnosis.

Precautions & Warnings

Store at room temperature away from light and moisture. Keep out of reach of children and pets. Discard used syringes properly in a sharps container. Report any unusual reactions to your healthcare provider promptly. Avoid sudden discontinuation without medical guidance.

Avoid Interactions

Avoid alcohol while using this medication as it may increase drowsiness. Certain medications like strong CYP3A4 inhibitors or inducers can affect aripiprazole levels. Inform your doctor about all prescription and over-the-counter products you use. Grapefruit products may interact with this drug.

Frequently Asked Questions

It is used to treat schizophrenia and maintain stability in bipolar I disorder as a long-acting injection.

This medication is typically administered once monthly by a healthcare professional.

Prescription medications require a valid prescription; consult your healthcare provider for availability.

Possible side effects include injection site pain, nausea, or dizziness. Report persistent issues to your doctor.

No, aripiprazole is not classified as a controlled substance.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.